EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dihydrotanshinone I Targets PGAM1 to Induce SYVN1 ‐Mediated Ubiquitination and Suppress Glycolysis in Hepatocellular Carcinoma

Ru Xu, Jiawei Dai, Ruijie Gong, Ruoxin Tu, Qiaozi Wang, Hongdan Zheng, Li Zhou, Shusheng Wang, Jiabin Cai, Haixiang Sun, Pingting Gao, Pengfei Gao

Phytotherapy Research · 2025-08 · 39 (8) · 3762-3783

DOI: 10.1002/ptr.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 10.07.2025. Verfasst von Ru Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Jinshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Glycolysis, Liver Neoplasms, Phosphoglycerate Mutase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jinshan District Health Commission, Natural Science Foundation of Fujian Province, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphoglycerate mutase 1 (PGAM1) is a glycolytic enzyme frequently overexpressed in hepatocellular carcinoma (HCC), contributing to tumor progression through aberrant glycolysis. Dihydrotanshinone I (DHT), a bioactive natural compound derived from Salvia miltiorrhiza , has been proposed as a potential therapeutic agent for HCC. This study aims to characterize DHT as a PGAM1‐targeting agent and investigate its anti‐HCC effects. We assessed the effects of DHT on PGAM1 regulation and glycolytic activity in vitro and in vivo. Using proteasomal degradation assays, we evaluated the role of Synoviolin 1 (SYVN1), an E3 ubiquitin ligase, in mediating the ubiquitination and degradation of PGAM1. The impact of DHT on key glycolytic enzymes, glucose consumption, lactate production, and ATP levels was also measured. In vivo, orthotopic and subcutaneous xenograft HCC models were used to evaluate tumor growth suppression following DHT treatment. DHT induced SYVN1‐mediated K48‐linked polyubiquitination and proteasomal degradation of PGAM1, disrupting glycolytic flux by reducing hexokinase and pyruvate kinase activities, decreasing glucose consumption, lactate production, and ATP levels. In vivo, DHT demonstrated dose‐responsive tumor suppression without observable short‐term toxicity. These findings establish DHT as a promising therapeutic agent for HCC by targeting PGAM1 degradation and disrupting glycolysis. The study provides a mechanistic framework for developing plant‐derived therapeutics targeting metabolic pathways in liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularGlycolysisLiver NeoplasmsPhosphoglycerate MutasePhenanthrenesUbiquitin-Protein LigasesQuinonesHumansAnimalsUbiquitinationMiceCell Line, TumorHep G2 CellsMice, NudeMice, Inbred BALB CMaleXenograft Model Antitumor AssaysFurans

Stichwörter der Autor:innen

PGAM1SYVN1dihydrotanshinone I (DHT)glycolysishepatocellular carcinoma (HCC)ubiquitination

Substanzen

Phosphoglycerate MutasePhenanthrenesdihydrotanshinone Iphosphoglycerate mutase 1, humanUbiquitin-Protein LigasesQuinonesFurans

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
  • Institute of Biomedical Sciences, Fudan University, Shanghai, China.
  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Liver Surgery and Transplantation, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
  • Endoscopy Center and Endoscopy Research Institute, Fudan University, Shanghai, China.

Förderung

  • Jinshan District Health Commission
  • Natural Science Foundation of Fujian Province
  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Xu, R., Dai, J., Gong, R., Tu, R., Wang, Q., Zheng, H., Zhou, L., Wang, S., Cai, J., Sun, H., Gao, P., & Gao, P. (2025). Dihydrotanshinone I Targets PGAM1 to Induce SYVN1 ‐Mediated Ubiquitination and Suppress Glycolysis in Hepatocellular Carcinoma. Phytotherapy Research, 39(8), 3762-3783. https://doi.org/10.1002/ptr.70017

Vancouver

Xu R, Dai J, Gong R, Tu R, Wang Q, Zheng H, et al. Dihydrotanshinone I Targets PGAM1 to Induce SYVN1 ‐Mediated Ubiquitination and Suppress Glycolysis in Hepatocellular Carcinoma. Phytotherapy Research. 2025;39(8):3762-3783. doi:10.1002/ptr.70017

BibTeX
@article{Xu2025,
  author = {Xu, Ru and Dai, Jiawei and Gong, Ruijie and Tu, Ruoxin and Wang, Qiaozi and Zheng, Hongdan and Zhou, Li and Wang, Shusheng and Cai, Jiabin and Sun, Haixiang and Gao, Pingting and Gao, Pengfei},
  title = {Dihydrotanshinone I Targets PGAM1 to Induce SYVN1 ‐Mediated Ubiquitination and Suppress Glycolysis in Hepatocellular Carcinoma},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {8},
  pages = {3762--3783},
  doi = {10.1002/ptr.70017}
}
Kostenlos starten →